Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marisa Jones"'
Autor:
Kathleen Van Manen-Brush, Jacob Zeitler, John R White, Paul Younge, Samantha Willis, Marisa Jones
Publikováno v:
BioTechniques, Vol 69, Iss 3, Pp 186-192 (2020)
Chinese hamster ovary (CHO) cells are a mammalian cell line used in the production of therapeutic proteins. Host cell proteins (HCPs) are process-related impurities that are derived from the host cell expression system. During biopharmaceutical drug
Externí odkaz:
https://doaj.org/article/1fcc32b0ba1645b7b6328b8fe1c3cbf3
Autor:
Shu-Min Zhang, Matthew Roberts, Marisa Jones, Jacob Zeitler, Greg Kilby, Aston Liu, John R White
Publikováno v:
BioTechniques, Vol 68, Iss 6, Pp 353-358 (2020)
Polyethyleneimine (PEI) is a flocculent that is widely used in the downstream purification of monoclonal antibodies. It is an in-process residual that is carried through the drug purification process and strongly inhibits residual DNA quantitation by
Externí odkaz:
https://doaj.org/article/9ab2508e54994f6785b529f2abe5e12d
Autor:
Marisa Jones, Fengqiang Wang, Nisha Palackal, Lei Zhang, Emily Menesale, Nicole S Schonenbach, Thomas Waerner, Karen Hurkmans, Yiwei Zhao, Georgeen Gaza-Bulseco, Séverine Clavier, Satish Sharma, Trish Connolly, Pascal Valax, Suli Liu, Carmelata Chitikila
Publikováno v:
Biotechnology and Bioengineering. 118:2870-2885
Host cell proteins (HCPs) are process-related impurities that may copurify with biopharmaceutical drug products. Within this class of impurities there are some that are more problematic. These problematic HCPs can be considered high-risk and can incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69bca1ceeb08bd54a56d5b28d66bdecd
https://doi.org/10.1002/bit.27808
https://doi.org/10.1002/bit.27808
Autor:
Carmelata Chitikila, Thomas Waerner, Karen Hurkmans, Yiwei Zhao, Lei Zhang, Marisa Jones, Nisha Palackal, Suli Liu, Nicole S Schonenbach, Patricia Connolly, Séverine Clavier, Satish Sharma, Fengqiang Wang, Emily Menesale, Georgeen Gaza-Bulseco
Host cell proteins (HCPs) are process-related impurities that may co-purify with biopharmaceutical drug products. Within this class of impurities there are some that are more problematic. These problematic HCPs can be considered high-risk and can inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4baef39d0f1d0dbf7cce5c3a66893138
https://doi.org/10.22541/au.160266604.42218591/v1
https://doi.org/10.22541/au.160266604.42218591/v1
Autor:
Jacob Zeitler, John R. White, Greg Kilby, Aston Liu, Marisa Jones, Matthew Roberts, Shu-Min Zhang
Publikováno v:
BioTechniques. 68(6)
Polyethyleneimine (PEI) is a flocculent that is widely used in the downstream purification of monoclonal antibodies. It is an in-process residual that is carried through the drug purification process and strongly inhibits residual DNA quantitation by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ddc000e9b49064323e3cff71995c839
https://pubmed.ncbi.nlm.nih.gov/32228190
https://pubmed.ncbi.nlm.nih.gov/32228190
Autor:
Elizabeth Handorf, Katrina Armstrong, Erin McGuire, Leigh Boghossian, Jinbo Chen, Anne Marie McCarthy, Marisa Jones, Susan M. Domchek, Mirar Bristol Demeter, Emily F. Conant
Publikováno v:
Breast Cancer Research and Treatment. 138:889-898
Breast cancer risk prediction remains imperfect, particularly among non-white populations. This study examines the impact of including single-nucleotide polymorphism (SNP) alleles in risk prediction for white and African American women undergoing scr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d571011a0d7a4f676dbd3d9528216a
https://doi.org/10.1007/s10549-013-2471-8
https://doi.org/10.1007/s10549-013-2471-8
Autor:
Marisa Jones, Katherine L. Nathanson, Jacquelyn Powers, Susan M. Domchek, Leigh Boghossian, Jill Stopfer, J. V. Cohen, L. Chiel, Timothy R. Rebbeck
Publikováno v:
Familial Cancer. 11:69-75
Risk-reducing salpingo-oophorectomy (RRSO) significantly reduces the risk of ovarian cancer and breast cancer in pre-menopausal women with BRCA1 and BRCA2 (B1/2) mutations. Despite its clear benefits, little is known about non-cancer endpoints in thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f12d8181b7587c36a04870c2933e971
https://doi.org/10.1007/s10689-011-9480-8
https://doi.org/10.1007/s10689-011-9480-8
Autor:
Tohru Hirato, Amol Ketkar, Yoshikazu Komurasaki, Yae Ito, Lin Bai, Atsushi Sugimura, Michael Adams, Shing Mai, Roxana Ionescu, Marisa Jones, Haiyan Liu, Yukichi Hatano, Oscar Lara-Velasco, Kazutoshi Mihara
Publikováno v:
Journal of pharmaceutical sciences. 104(12)
One major concern with biosimilars is that small differences compared with reference products might lead to unforeseen immunogenicity, thus affecting patient safety and drug efficacy. Differences could be due to either post-translational modification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06581f93a2b30f47eb4a7fcaf5d8a170
https://pubmed.ncbi.nlm.nih.gov/26367379
https://pubmed.ncbi.nlm.nih.gov/26367379
Autor:
Hooser, Marisa Jones.
Publikováno v:
Electronic version of thesis.
Thesis (M.A.)--Marshall University, 2001.
Typescript. Includes bibliographical references (leaves I-V).
Typescript. Includes bibliographical references (leaves I-V).
Autor:
Anne Marie McCarthy, Marisa Jones, Katrina Armstrong, Erin McGuire, Susan M. Domchek, Mirar Bristol Demeter, Despina Kontos, Leigh Boghossian, Emily F. Conant
Publikováno v:
Cancer Research. 73:2528-2528
Background: Women with BIRADS 4 mammograms are referred for biopsy and have a 15-30% one year risk of breast cancer. Identifying pre-test predictors of cancer among women with BIRADS 4 mammograms may be useful in reducing false-positives. Methods: Wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97a925df34f766706c65059da9c05ad5
https://doi.org/10.1158/1538-7445.am2013-2528
https://doi.org/10.1158/1538-7445.am2013-2528